Search
Search Results
-
Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses
PoxvirusesPoxviruses target innate immunity mediators such as tumor necrosis factors, interleukins, interferons, complement, and chemokines. It also...
-
Monkeypox Diagnosis in Clinical Settings: A Comprehensive Review of Best Laboratory Practices
An outbreakOutbreak of monkeypox (Mpox) was reported in more than 40 countries in early 2022. Accurate diagnosisDiagnosis of MpoxMpox can be...
-
Zoonotic and Zooanthroponotic Potential of Monkeypox
The current multicounty outbreak of monkeypox virus (MPXVMPXV) posed an emerging and continued challenge to already strained public healthcare...
-
Monkeypox: Past, Present, and Future
MonkeypoxMonkeypox (Mpox) is a zoonotic disease caused by a virus (monkeypox virusMonkeypox virus-MPV) belonging to the Poxviridae family. In humans,...
-
Assembly and Evolution of Poxviruses
Poxvirus assemblyPoxvirus assembly has been an intriguing area of research for several decades. While advancements in experimental techniques...
-
Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus
Poxviruses are large (200–450 nm) and enveloped viruses carrying double-stranded DNA genome with an epidermal cell-specific adaptation. The genus...
-
The Future of Atopic Dermatitis Treatment
This chapter thoroughly examines recent breakthroughs in atopic dermatitis (AD) treatment, with a primary focus on the medications in the development...
-
Atopic Dermatitis: Disease Background and Risk Factors
Multiple risk factors have been associated with the development of atopic dermatitis (AD). Recent advances in understanding the role of genetics in...
-
Special Considerations of Atopic Dermatitis in Skin of Color
Atopic dermatitis (AD) is a chronic inflammatory skin condition with heterogeneous presentations and prevalence across different skin tones. In this...
-
Systemic Biologic Management of Atopic Dermatitis
Dupilumab and tralokinumab are currently the only FDA-approved biologic therapies for the treatment of moderate-to-severe atopic dermatitis....
-
Oral Prescription Management
The treatment of atopic dermatitis (AD) with oral treatments has been limited in the past due to the increased risk of adverse effects associated...
-
Inflammation and Cardiovascular Outcomes
This chapter provides an updated review of our understanding of the role played by inflammation in the development and progression of atherosclerotic...
-
Challenges in Develo** Evidence-Based Recommendations for Non-Pharmacological Interventions for Atherosclerotic Cardiovascular Disease Risk Reduction
Non-pharmacological interventions are the cornerstone of atherosclerotic cardiovascular disease (ASCVD) risk reduction. Develo** evidence-based...
-
An Overview of the Guideline Development Process for Atherosclerotic Cardiovascular Disease Risk Reduction with an Emphasis on Guidelines for Cholesterol and Dyslipidemia Management
Clinical practice guidelines for lipid management of atherosclerotic cardiovascular disease (ASCVD) are to be used in combination with clinical...
-
Chronic Kidney Disease and Cardiovascular Outcomes
Cardiovascular disease (CVD) is the primary cause of mortality in patients with chronic kidney disease (CKD). Cardiorenal syndromes encompass several...
-
Cardiovascular Disease Risk and Risk Reduction Strategies in Diabetes Mellitus
Diabetes mellitus, a condition characterized by glucose dysregulation resulting in chronic hyperglycemia, is principally caused by autoimmune...
-
Lifestyle Interventions and Atherosclerotic Cardiovascular Disease Outcomes
A healthy lifestyle across the lifespan is the foundation for the prevention of atherosclerotic cardiovascular disease (ASCVD). Lifestyle...
-
Cardiac Rhythms and Cardiovascular Outcomes
The field of cardiac electrophysiology is young and rapidly evolving with a wealth of outcomes data continually added to the literature. This chapter...
-
Innovations in Tuberculosis Disease Screening
Tuberculosis (TB), an infectious disease caused by mycobacterium tuberculosis (M. tb), is the number one cause of death from an infectious agent...
-
A Comprehensive Review of Algorithms Developed for Rapid Pathogen Detection and Surveillance
The chapter discusses the importance of early detection and surveillance of infectious diseases, including the recent COVID-19 pandemic and the...